Get started
Author

Шаньшин Даниил Васильевич

Observed names: D. V. Shan'shin, D. V. Shanshin, D. V. Shan’shin, D.V. Shanshin, Daniil Shanshin, Daniil V. Shanshin, Shanshin D.V. Shanshin, Д. В. Шаньшин, Шаньшин, Даниил
ORCID: 0000-0001-9985-1582
Observed ORCIDs: 0000-0001-9985-1582, 0000-0003-3682-2287
OpenAlex ID: A5017773589
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
2021 · Dmitriy Shcherbakov, Dmitriy Baev, et al. · ACS Medicinal Chemistry Letters · 59
PDF
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
2022 · Iuliia A. Merkuleva, Dmitry N. Shcherbakov, et al. · Vaccines · 41
PDF
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
2022 · Mariya B. Borgoyakova, Larisa I. Karpenko, et al. · International Journal of Molecular Sciences · 29
PDF
Structure‐ and Interaction‐Based Design of Anti‐SARS‐CoV‐2 Aptamers
2022 · Vladimir Mironov, Irina A. Shchugoreva, et al. · Chemistry - A European Journal · 27
Single-domain antibody C7b for address delivery of nanoparticles to HER2-positive cancers
2020 · Yuri A. Vorotnikov, Evgeniya D. Novikova, et al. · Nanoscale · 26
Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
2021 · M. B. Borgoyakova, L. I. Karpenko, et al. · Molecular Biology · 24
PDF
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
2022 · Iuliia A. Merkuleva, Dmitry N. Shcherbakov, et al. · Viruses · 17
PDF
Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses?
2022 · Daniil V. Shanshin, Sophia S. Borisevich, et al. · International Journal of Molecular Sciences · 11
PDF
IgG Study of Blood Sera of Patients with COVID-19
2021 · Elena Kazachinskaia, Alexander Chepurnov, et al. · Pathogens · 9
PDF
Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Hydrolyze Recombinant RBD and Nucleocapsid (N) Proteins
2024 · Anna M. Timofeeva, Liliya Sh. Shayakhmetova, et al. · Biomedicines · 7
The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
2023 · Svetlana V. Belenkaya, Iuliia A. Merkuleva, et al. · Frontiers in Bioengineering and Biotechnology · 6
PDF
Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19
2022 · Evgeniia A. Kolosova, Olga N. Shaprova, et al. · Journal of Clinical Medicine · 5
PDF
Development of Search Strategy for Peptide Inhibitors of Immune Checkpoints
2018 · S. V. Podlesnykh, D. V. Shanshin, et al. · Russian Journal of Bioorganic Chemistry · 4
Иммуногенные свойства ДНК-конструкции, кодирующей рецепторсвязывающий домен белка шипа SARS-CoV-2
2021 · М. Б. Боргоякова, Л. И. Карпенко, et al. · Molecular Biology · 3
DNA-protein COVID-19 combination vaccine containing multiepitope T-cell immunogen and receptor binding domain of the SARS-CoV-2 S protein
2025 · Mariya B. Borgoyakova, Andrey P. Rudometov, et al. · Journal of microbiology epidemiology immunobiology · 2
PDF
Preparation and Construction of Chimeric Humanized Broadly Reactive Antibody 10H10 to Protein E of Tick-Borne Encephalitis Virus
2024 · D. V. Shanshin, V. S. Nesmeyanova, et al. · Bulletin of Experimental Biology and Medicine · 2
Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper
2023 · Svetlana V. Belenkaya, Iuliia A. Merkuleva, et al. · Frontiers in Bioengineering and Biotechnology · 2
PDF
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
2022 · M. B. Borgoyakova, L. I. Karpenko, et al. · Bulletin of Experimental Biology and Medicine · 2
PDF
Cover Feature: Structure‐ and Interaction‐Based Design of Anti‐SARS‐CoV‐2 Aptamers (Chem. Eur. J. 12/2022)
2022 · Vladimir Mironov, Irina A. Shchugoreva, et al. · Chemistry - A European Journal · 2
PDF
An interaction of Zika virus envelope fragments with serum antibodies derived from subjects after flavivirus infections
2020 · D. V. Shanshin, A. Yu. Bakulina, et al. · Russian Journal of Infection and Immunity · 2
PDF
Method for express-detection of recombinant West Nile Virus E protein
2025 · A. A. Cheremiskina, D. V. Shanshin, et al. · Measurement Techniques · 1
Construction of an Integration Vector with a Chimeric Signal Peptide for the Expression of Monoclonal Antibodies in Mammalian Cells
2024 · Valentina S. Nesmeyanova, Daniil V. Shanshin, et al. · Current Issues in Molecular Biology · 1
PDF
Phage Display Revealed the Complex Structure of the Epitope of the Monoclonal Antibody 10H10
2024 · Daniil V. Shanshin, Sophia S. Borisevich, et al. · International Journal of Molecular Sciences · 1
PDF
Problematic questions in the development of specific prevention of dengue fever
2022 · E. I. Kazachinskaia, D. V. Shanshin, et al. · Medical Immunology (Russia) · 1
PDF
Zika Fever: Development of Diagnostics, Prevention and Treatment
2019 · E. I. Kazachinskaya, D. V. Shan’shin, et al. · Problems of Particularly Dangerous Infections · 1
PDF
Works count: 42
Citation count: 286
H-index: 9
I10-index: 8
Year
Topic
Type